Ameriprise’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-42,527
Closed -$142K 4005
2025
Q1
$142K Sell
42,527
-20,021
-32% -$66.7K ﹤0.01% 3804
2024
Q4
$463K Sell
62,548
-494,986
-89% -$3.66M ﹤0.01% 3527
2024
Q3
$5.24M Buy
557,534
+529,535
+1,891% +$4.97M ﹤0.01% 2344
2024
Q2
$225K Sell
27,999
-23,997
-46% -$192K ﹤0.01% 3672
2024
Q1
$771K Buy
51,996
+24,476
+89% +$363K ﹤0.01% 3277
2023
Q4
$224K Buy
27,520
+1,085
+4% +$8.82K ﹤0.01% 3699
2023
Q3
$120K Buy
+26,435
New +$120K ﹤0.01% 3776
2023
Q2
Sell
-143,013
Closed -$874K 3949
2023
Q1
$874K Sell
143,013
-1,168,247
-89% -$7.14M ﹤0.01% 3218
2022
Q4
$8.38M Sell
1,311,260
-1,200,907
-48% -$7.67M ﹤0.01% 1890
2022
Q3
$24.1M Sell
2,512,167
-497,847
-17% -$4.77M 0.01% 1071
2022
Q2
$33.2M Buy
3,010,014
+488,509
+19% +$5.39M 0.01% 904
2022
Q1
$42M Buy
2,521,505
+51,796
+2% +$862K 0.01% 885
2021
Q4
$47.2M Buy
2,469,709
+298,109
+14% +$5.69M 0.01% 872
2021
Q3
$53.6M Buy
2,171,600
+885,153
+69% +$21.8M 0.02% 740
2021
Q2
$33.5M Buy
1,286,447
+832,124
+183% +$21.7M 0.01% 996
2021
Q1
$14.4M Buy
454,323
+116,815
+35% +$3.7M ﹤0.01% 1574
2020
Q4
$15.7M Buy
337,508
+91,843
+37% +$4.26M 0.01% 1415
2020
Q3
$8.09M Buy
245,665
+234,775
+2,156% +$7.73M ﹤0.01% 1710
2020
Q2
$292K Buy
10,890
+1,810
+20% +$48.5K ﹤0.01% 3371
2020
Q1
$225K Buy
+9,080
New +$225K ﹤0.01% 3406
2018
Q2
Sell
-71,201
Closed -$1.2M 3652
2018
Q1
$1.2M Buy
+71,201
New +$1.2M ﹤0.01% 2889
2014
Q4
Sell
-180
Closed -$1K 4054
2014
Q3
$1K Buy
+180
New +$1K ﹤0.01% 5508